• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膀胱过度活动症满意度(OAB-S)问卷的编制与验证

Development and validation of the Overactive Bladder Satisfaction (OAB-S) Questionnaire.

作者信息

Piault Elisabeth, Evans Christopher J, Espindle Derek, Kopp Zoe, Brubaker Linda, Abrams Paul

机构信息

Mapi Values, Boston, Massachusetts 02108, USA.

出版信息

Neurourol Urodyn. 2008;27(3):179-90. doi: 10.1002/nau.20455.

DOI:10.1002/nau.20455
PMID:17565727
Abstract

AIMS

To develop and validate a measure of patient satisfaction with treatment in overactive bladder: the Overactive Bladder Satisfaction Questionnaire (OAB-S).

METHODS

Development of the questionnaire included a comprehensive literature review, development of a conceptual model, item elicitation and cognitive debriefing interviews with US-English and US-Spanish patients, and assessment of the questionnaire's translatability in other languages. Psychometric validation of the questionnaire was run on a longitudinal, non-randomized study involving 201 OAB patients. Analyses included construct validity, concurrent validity, tests of reliability, known-group validity, and responsiveness (exploratory).

RESULTS

The OAB-S is a patient-completed questionnaire including five scales: OAB Control Expectations (ten items); Impact on Daily Living with OAB (ten items); OAB Control (ten items); OAB Medication Tolerability (six items); and Satisfaction with Control (ten items) and five single-item overall assessments of patient's fulfillment of OAB medication expectations, interruption of day-to-day life due to OAB, overall satisfaction with OAB medication; willingness to continue OAB medication and improvement in day-to-day life due to OAB medication. The hypothesized structure of the questionnaire was supported by statistical analyses. Internal consistency reliability coefficients (ranging from 0.76 to 0.94) and test-retest reliability coefficients (ranging from 0.72 to 0.87) were good for all dimensions. All dimensions except tolerability discriminated well according to self-reported OAB severity level and incontinence status.

CONCLUSION

The OAB-S is a valid, comprehensive instrument to assess satisfaction with treatment of OAB based on independent scales that have demonstrated satisfactory psychometric performance.

摘要

目的

开发并验证一种用于评估膀胱过度活动症患者治疗满意度的量表:膀胱过度活动症满意度问卷(OAB-S)。

方法

该问卷的开发包括全面的文献综述、概念模型的构建、条目征集以及对美国英语和美国西班牙语患者进行的认知反馈访谈,还评估了问卷在其他语言中的可翻译性。对该问卷的心理测量学验证是在一项涉及201名膀胱过度活动症患者的纵向、非随机研究中进行的。分析包括结构效度、同时效度、信度测试、已知组效度和反应性(探索性)。

结果

OAB-S是一份由患者自行完成的问卷,包括五个量表:膀胱过度活动症控制期望(10个条目);膀胱过度活动症对日常生活的影响(10个条目);膀胱过度活动症控制(10个条目);膀胱过度活动症药物耐受性(6个条目);以及对控制的满意度(10个条目),还有对患者膀胱过度活动症药物期望的达成情况、因膀胱过度活动症导致的日常生活中断、对膀胱过度活动症药物的总体满意度、继续使用膀胱过度活动症药物的意愿以及因膀胱过度活动症药物导致的日常生活改善情况的五项单项总体评估。问卷的假设结构得到了统计分析的支持。所有维度的内部一致性信度系数(范围为0.76至0.94)和重测信度系数(范围为0.72至0.87)都很好。除耐受性外,所有维度根据自我报告的膀胱过度活动症严重程度和尿失禁状态都有良好的区分度。

结论

OAB-S是一种有效的、综合性的工具,可基于已证明具有令人满意的心理测量学性能的独立量表来评估膀胱过度活动症治疗的满意度。

相似文献

1
Development and validation of the Overactive Bladder Satisfaction (OAB-S) Questionnaire.膀胱过度活动症满意度(OAB-S)问卷的编制与验证
Neurourol Urodyn. 2008;27(3):179-90. doi: 10.1002/nau.20455.
2
Psychometric validation of the overactive bladder satisfaction with treatment questionnaire (OAB-SAT-q).膀胱过度活动症治疗满意度问卷(OAB-SAT-q)的心理测量学验证
Neurourol Urodyn. 2009;28(5):416-22. doi: 10.1002/nau.20672.
3
The psychometric validation of the OAB family impact measure (OAB-FIM).OAB 家庭影响量表(OAB-FIM)的心理测量学验证。
Neurourol Urodyn. 2010 Mar;29(3):359-69. doi: 10.1002/nau.20715.
4
Comprehensive evaluation of bladder and urethral dysfunction symptoms: development and psychometric validation of the Urinary Symptom Profile (USP) questionnaire.膀胱和尿道功能障碍症状的综合评估:尿症状概况(USP)问卷的编制及心理测量学验证
Urology. 2008 Apr;71(4):646-56. doi: 10.1016/j.urology.2007.11.100. Epub 2008 Mar 3.
5
Test-retest reliability of four questionnaires for patients with overactive bladder: the overactive bladder questionnaire (OAB-q), patient perception of bladder condition (PPBC), urgency questionnaire (UQ), and the primary OAB symptom questionnaire (POSQ).四种膀胱过度活动症患者问卷的重测信度:膀胱过度活动症问卷(OAB-q)、患者膀胱状况感知问卷(PPBC)、尿急问卷(UQ)以及原发性膀胱过度活动症症状问卷(POSQ)。
Neurourol Urodyn. 2005;24(3):215-25. doi: 10.1002/nau.20110.
6
Symptom severity and patient perceptions in overactive bladder: how are they related?膀胱过度活动症的症状严重程度和患者感知:它们之间有何关联?
BJU Int. 2009 Oct;104(7):968-72. doi: 10.1111/j.1464-410X.2009.08498.x. Epub 2009 Mar 10.
7
Reliability and validity of the Overactive Bladder Symptom Score in Spanish (OABSS-S).西班牙语版过度膀胱症状评分(OABSS-S)的信度和效度。
Neurourol Urodyn. 2012 Jun;31(5):664-8. doi: 10.1002/nau.21235. Epub 2012 Apr 4.
8
Psychometric evaluation of the medical outcomes study-sleep scale in persons with overactive bladder.膀胱过度活动症患者医学结局研究睡眠量表的心理测量学评估
Clin Ther. 2006 Dec;28(12):2119-32. doi: 10.1016/j.clinthera.2006.12.008.
9
Effects of tolterodine ER on patient-reported outcomes in sexually active women with overactive bladder and urgency urinary incontinence.托特罗定缓释片对患有膀胱过度活动症和急迫性尿失禁的性活跃女性患者报告结局的影响。
Curr Med Res Opin. 2009 Sep;25(9):2159-65. doi: 10.1185/03007990903103279.
10
Validation of treatment benefit scale for assessing subjective outcomes in treatment of overactive bladder.用于评估膀胱过度活动症治疗主观结局的治疗获益量表的验证
Urology. 2008 Oct;72(4):803-7. doi: 10.1016/j.urology.2008.05.033. Epub 2008 Aug 22.

引用本文的文献

1
Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN II) Urinary Urgency Phenotyping Study: Methods and Baseline Urinary Symptoms by Age and Sex.下尿路功能障碍研究网络(LURN II)尿急症状分型研究:方法及按年龄和性别划分的基线尿路症状
Neurourol Urodyn. 2025 Jun;44(5):1007-1021. doi: 10.1002/nau.70044. Epub 2025 Apr 24.
2
Patient-reported outcome measures for medication treatment satisfaction: a systematic review of measure development and measurement properties.患者报告的药物治疗满意度测量指标:测量开发和测量特性的系统评价。
BMC Med. 2024 Sep 2;22(1):347. doi: 10.1186/s12916-024-03560-3.
3
Urodynamic efficacy of fesoterodine for the treatment of neurogenic detrusor overactivity and/or low compliance bladder.
非索罗定治疗神经源性逼尿肌过度活动和/或顺应性膀胱的尿动力学疗效。
Int J Urol. 2020 Oct;27(10):899-904. doi: 10.1111/iju.14319. Epub 2020 Aug 7.
4
Factors Associated with Improvements in Patient-Reported Outcomes During Mirabegron or Antimuscarinic Treatment of Overactive Bladder Syndrome: A Registry Study (PERSPECTIVE).米拉贝隆或抗毒蕈碱药物治疗膀胱过度活动症患者报告结局改善的相关因素:一项注册研究(观点)。
Adv Ther. 2019 Aug;36(8):1906-1921. doi: 10.1007/s12325-019-00994-7. Epub 2019 Jun 20.
5
A patient-reported, non-interventional, cross-sectional discrete choice experiment to determine treatment attribute preferences in treatment-naïve overactive bladder patients in the US.一项由患者报告的、非干预性的横断面离散选择实验,旨在确定美国初治膀胱过度活动症患者对治疗属性的偏好。
Patient Prefer Adherence. 2018 Oct 12;12:2139-2152. doi: 10.2147/PPA.S178668. eCollection 2018.
6
Emerging good practices for Translatability Assessment (TA) of Patient-Reported Outcome (PRO) measures.患者报告结局(PRO)指标可翻译性评估(TA)的新兴良好实践。
J Patient Rep Outcomes. 2017;2(1):8. doi: 10.1186/s41687-018-0035-8. Epub 2018 Feb 21.
7
Patient-reported outcomes in patients with overactive bladder treated with mirabegron and tolterodine in a prospective, double-blind, randomized, two-period crossover, multicenter study (PREFER).一项前瞻性、双盲、随机、两周期交叉、多中心研究(PREFER)显示,米拉贝隆和托特罗定治疗膀胱过度活动症患者的患者报告结局。
Health Qual Life Outcomes. 2018 Apr 19;16(1):69. doi: 10.1186/s12955-018-0892-0.
8
A prospective, double-blind, randomized, two-period crossover, multicenter study to evaluate tolerability and patient preference between mirabegron and tolterodine in patients with overactive bladder (PREFER study).一项前瞻性、双盲、随机、两阶段交叉、多中心研究,旨在评估米拉贝隆与托特罗定在膀胱过度活动症患者中的耐受性及患者偏好(PREFER研究)。
Int Urogynecol J. 2018 Feb;29(2):273-283. doi: 10.1007/s00192-017-3377-5. Epub 2017 Jun 15.
9
The satisfaction of patients with refractory idiopathic overactive bladder with onabotulinumtoxinA and augmentation cystoplasty.难治性特发性膀胱过度活动症患者使用A型肉毒毒素和膀胱扩大术的满意度
Arab J Urol. 2013 Dec;11(4):344-9. doi: 10.1016/j.aju.2013.07.003. Epub 2013 Aug 12.
10
Review of the efficacy and safety of fesoterodine for treating overactive bladder and urgency urinary incontinence in elderly patients.非索罗定治疗老年患者膀胱过度活动症和急迫性尿失禁的疗效及安全性综述。
Drugs Aging. 2015 Feb;32(2):103-25. doi: 10.1007/s40266-014-0237-6.